These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26279047)

  • 1. In Reply to Levra et al.
    Arvold ND; Tanguturi SK; Alexander BM
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):218-9. PubMed ID: 26279047
    [No Abstract]   [Full Text] [Related]  

  • 2. In Regard to Arvold et al.
    Fiorica F; Colella M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):939. PubMed ID: 26530769
    [No Abstract]   [Full Text] [Related]  

  • 3. In reply to Gondi and Mehta.
    Huang J; Robinson CG; Badiyan SN
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):454-5. PubMed ID: 25636773
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation as a foundation for glioblastoma therapy in elderly patients. In Regard to Arvold et al.
    Giaj Levra N; Fiorentino A; Fersino S; Ricchetti F; Mazzola R; Alongi F
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):217-8. PubMed ID: 26279046
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose escalation for GBM in the temozolamide era: in regard to Badiyan et al.
    Gondi V; Mehta MP
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):453-4. PubMed ID: 25636772
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic radiotherapy for glioblastoma in the elderly.
    Tartarone A; Ardito R; Romano C
    N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of brain tumors.
    Ashby L; LaRocca R; Ryken T
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938013
    [No Abstract]   [Full Text] [Related]  

  • 8. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
    Hamilton DA
    Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant temozolomide: how long and how much?
    Franceschi E; Tosoni A; Brandes AA
    Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of brain tumors.
    Seiter K
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938012
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005).
    Jalali R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1622; author reply 1622-3. PubMed ID: 19028293
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy for brain tumors--a new beginning.
    DeAngelis LM
    N Engl J Med; 2005 Mar; 352(10):1036-8. PubMed ID: 15758016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to T.J. Kruser et al.
    Chinot OL; Taphoorn MJ; Bais C; Bourgon R; Phillips HS; Abrey LE; Wick W; Mason W; Henriksson R; Saran F; Nishikawa R; Cloughesy T
    J Clin Oncol; 2016 Apr; 34(11):1282-3. PubMed ID: 26884575
    [No Abstract]   [Full Text] [Related]  

  • 15. Going past the data for temozolomide.
    Villano JL; Letarte N; Bressler LR
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status quo--standard-of-care medical and radiation therapy for glioblastoma.
    Becker KP; Yu J
    Cancer J; 2012; 18(1):12-9. PubMed ID: 22290252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.
    Cahill DP; Codd PJ; Batchelor TT; Curry WT; Louis DN
    Clin Neurosurg; 2008; 55():165-71. PubMed ID: 19248684
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for glioblastoma multiforme (GBM).
    Roitberg B
    Surg Neurol; 2006 Feb; 65(2):107-8. PubMed ID: 16427394
    [No Abstract]   [Full Text] [Related]  

  • 20. Can We Predict Bevacizumab Responders in Patients With Glioblastoma?
    Mayer TM
    J Clin Oncol; 2015 Sep; 33(25):2721-2. PubMed ID: 26195699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.